In 2024, hospitalizations and deaths due to foodborne illnesses doubled. The FDA has also recently raised the flag on the emergence of unapproved GLP-1 drugs, which have been linked to 10 deaths and 100 hospitalizations in the United States.
Patients and consumers deserve better than this. Retailers and manufacturers of food and healthcare products need to ensure consumer safety and commit to patient care. The scale of our delivery systems is large, but that is no excuse for issues that fall through the cracks. With the proper approach to inventory governance empowered by vetted technology, ensuring product safety is more than doable—it’s critical.
THE PARADOX OF ADVANCING TECHNOLOGY AND RISING CONSUMER RISK
If safety and quality technology are improving, why are foodborne illnesses and patient safety incidents increasing? The issue is not technological capability but ownership, commitment, and accountability. The United States’ regulatory framework places disproportionate responsibility on the consumer. Warning labels shift the risk away from businesses and onto individuals, unlike in Europe, where regulations hold companies accountable at every level of the supply chain. When manufacturers, distributors, and retailers share responsibility, enterprises are incentivized to invest in safety measures that ensure no contamination, improper handling, or oversight leads to public harm.
Despite technological advancements, systemic gaps persist. Producing and distributing food and medicine products at the national scale creates margins of statistical error that are difficult to manage without rigorous oversight. A minor lapse in a high-volume production or distribution network can escalate into a national recall and associated safety risk. Without stringent regulation, adherence to best practices, and a commitment to preventive safety measures, technology alone cannot prevent foodborne illness outbreaks or unsafe drug distribution.
ACCOUNTABILITY IS EVOLVING REGULATORY LANDSCAPES
With regulatory environments constantly shifting, businesses must take proactive steps to align their day-to-day SOPs with consumer safety. The COVID-19 pandemic disrupted regulatory progress by pausing critical compliance measures. For example, in March 2020, the U.S. Food and Drug Administration (FDA) temporarily postponed all routine surveillance facility inspections to protect public health during the pandemic. This pause led to a significant reduction in oversight, with the FDA inspecting only 7% of facilities identified as “high-risk” for foodborne illnesses that year. Because of the variance in oversight from federal agencies, companies must choose to adopt rigorous safety measures independently to reduce the risk of consumer harm.
Organizations must implement comprehensive inventory governance systems, digital tracking, and stringent compliance checks. A proactive approach includes leveraging AI-driven monitoring, real-time supply chain transparency, and robust quality control measures. Investing in these solutions is not just about compliance—it is a commitment to consumer trust, brand reputation, and, most importantly, public safety.
THE RISKS AND BENEFITS OF SCALE IN PRODUCT SAFETY
Large organizations have greater command over their supply chains, enabling tighter control over product sourcing, storage, and distribution. This oversight allows for robust quality control, but when failures occur, the scale of recalls can be massive, affecting millions of consumers at once. A single disruption could result in widespread harm, making comprehensive oversight essential.
Smaller businesses, such as independent restaurants, may lack the capital to invest in advanced safety technology, but they often have closer relationships with suppliers and shorter product travel times. This proximity reduces the risk of contamination. However, without proper tracking and compliance tools, smaller operations remain vulnerable to lapses that may go undetected.
The solution lies in striking a balance. Large companies must pair their broad oversight with stringent safety measures, while smaller businesses should adopt scalable, cost-effective technologies to maintain product integrity. The ultimate goal is not just regulatory adherence but a culture of unwavering commitment to consumer safety.
To prevent future crises, businesses across all industries must reevaluate their approach to product safety. This includes shifting from reactive responses to proactive prevention, ensuring visibility across the supply chain, and embracing accountability to mitigate risks. The consumer should not be the last line of defense against unsafe products.
Enterprises that lead in safety are supporting public health while also strengthening their reputations and ensuring long-term success in increasingly competitive markets. Now is the time to recommit to product safety—not just because regulation may require it, but because consumers deserve nothing less.